Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning, Says Frost & Sullivan

For additional info on this evaluation, please go to: http://frost.ly/4l2.

“Applying data science tools in healthcare, especially for drug discovery, has a huge potential to systematically change the entire existing practices and methods,” stated Aarthi Janakiraman, Technical Insights Research Manager at Frost & Sullivan. “Additionally, pharmaceutical companies and hospitals are adopting this system rapidly, and its application is going to be established in all branches of healthcare.”

Janakiraman added: “Integrating AI and ML methods into drug discovery pipelines would cut down cost and time, and increase the efficiency of the entire research and development (R&D) process. Going forward, big pharma and mid-sized biotech companies can benefit by partnering with core AI startups and reducing the costs involved in setting up their own capabilities.”

Integrating information science in drug discovery and medical trials presents immense progress prospects for market individuals, together with:

  • Partnering with rising AI corporations will enhance analysis momentum and assist pace up medical trials.
  • Using AI for therapeutics and screening, together with for COVID-19, because it supplies entry to a big library of compounds and may current a decrease danger of sudden toxicity or unwanted effects in human trials.
  • Developing AI-assisted drug security and toxicity science which might be at a nascent stage, but evolving. This requires additional analysis and collaborations to guage the potential medical affect. Large quantities of newly accessible information present a possibility to leverage AI and ML to enhance drug security.
  • Modernizing medical trials because the FDA has created Master Clinical Trial Protocols (MAPs) to extend trial effectivity and decrease prices. MAPs use frequent medical trial infrastructure to streamline trial processes and improve information assortment.

Data Science Impacting the Pharmaceutical Industry is the newest addition to Frost & Sullivan’s Technical Insights analysis and analyses accessible by way of the Frost & Sullivan Leadership Council, which helps organizations establish a steady stream of progress alternatives to reach an unpredictable future.

About Frost & Sullivan

For over 5 many years, Frost & Sullivan has turn into world-renowned for its position in serving to buyers, company leaders and governments navigate financial modifications and establish disruptive applied sciences, Mega Trends, new enterprise fashions and firms to motion, leading to a steady stream of progress alternatives to drive future success. Contact us: Start the dialogue.

Data Science Impacting the Pharmaceutical Industry

D9B0

Contact:
Mariana Fernandez
Corporate Communications
P: +1 210 348 10 12
E: Mariana.Fernandez@frost.com
http://ww2.frost.com

Table of Contents

Related Links

www.frost.com

SOURCE Frost & Sullivan

LEAVE A REPLY

Please enter your comment!
Please enter your name here